InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Yilmaz Mahshid, Chief Financial Officer. Director active across 1 company, notably Egetis Therapeutics AB (publ). In total, 4 filings have been logged. History available since 26 November 2025. The latest transaction was filed on 11 May 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Companies and markets linked to Yilmaz Mahshid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
153,631 shares@ SEK 6.500.0037% mcap44.8% of flowAktieISIN SE0003815604FI:csv-fd45067293b119868f0a
264,880 shares0AktieISIN SE0003815604FI:csv-20298035c5d4dc97dbf5
153,631 shares@ SEK 6.500.0043% mcap81.3% of flowAktieISIN SE0003815604FI:A003Y582-1
60,000 shares@ €0.35090.0010% mcap18.7% of flowAktieISIN SE0003815604FI:A003U276-2
4 of 4 declarations
About Yilmaz Mahshid
Yilmaz Mahshid is the Chief Financial Officer of Egetis Therapeutics AB (publ). In this role, he is responsible for the financial management of the company, including budgeting and financial analysis. His expertise is essential to ensure the financial health of the organization.
